Effectiveness of COVID-19 Vaccines Against Hospitalization and Death With the SARS-CoV-2 Delta Variant in Solid Organ and Islet Transplant Recipients
Transplantation
.
2022 Jun 1;106(6):e310-e311.
doi: 10.1097/TP.0000000000004104.
Epub 2022 Mar 8.
Authors
Sarah V Williams
1
,
Heather J Whitaker
1
,
Lisa Mumford
2
,
Chris Callaghan
2
,
Rebecca M K Curtis
2
,
Julia Stowe
1
,
Freja Kirsebom
1
,
James Thomas
1
,
Ines Ushiro-Lumb
2
,
Rommel Ravanan
2
,
Jamie Lopez-Bernal
1
Affiliations
1
UK Health Security Agency, London, United Kingdom.
2
National Health Service Blood and Transplant, Stoke Gifford, Bristol, United Kingdom.
PMID:
35283455
PMCID:
PMC9128400
DOI:
10.1097/TP.0000000000004104
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines* / therapeutic use
COVID-19* / mortality
COVID-19* / prevention & control
Hospitalization
Humans
Organ Transplantation*
SARS-CoV-2
Transplant Recipients*
Substances
COVID-19 Vaccines
Supplementary concepts
SARS-CoV-2 variants